IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
SERPINB9 | Serpin peptidase inhibitor, clade B (ovalbumin), member 9 | | | | | | Mixed |
SERPINB6 | Serpin peptidase inhibitor, clade B (ovalbumin), member 6 | Disease related genes Plasma proteins
| | | | | Expressed in all |
SSR1 | Signal sequence receptor, alpha | Predicted membrane proteins
| | | | | Expressed in all |
RIOK1 | RIO kinase 1 | Enzymes
| | | | | Expressed in all |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
SIRT5 | Sirtuin 5 | FDA approved drug targets
| | | | | Expressed in all |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
LRRC16A | Leucine rich repeat containing 16A | | | | | | Mixed |
PPP1R18 | Protein phosphatase 1, regulatory subunit 18 | Cytoskeleton related proteins
| | | | | Expressed in all |
TUBB | Tubulin, beta class I | Cytoskeleton related proteins FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FLOT1 | Flotillin 1 | Plasma proteins
| | | | | Expressed in all |
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
CSNK2B | Casein kinase 2, beta polypeptide | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
VARS | Valyl-tRNA synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
EHMT2 | Euchromatic histone-lysine N-methyltransferase 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HLA-DRA | Major histocompatibility complex, class II, DR alpha | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
PSMB8 | Proteasome (prosome, macropain) subunit, beta type, 8 | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes
| | | | | Expressed in all |
DEF6 | Differentially expressed in FDCP 6 homolog (mouse) | | | | | | Expressed in all |
FKBP5 | FK506 binding protein 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MRPS10 | Mitochondrial ribosomal protein S10 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
KLHDC3 | Kelch domain containing 3 | | | | | | Expressed in all |
KLC4 | Kinesin light chain 4 | | | | | | Expressed in all |
SRF | Serum response factor (c-fos serum response element-binding transcription factor) | Transcription factors
| | | | | Expressed in all |
TMEM63B | Transmembrane protein 63B | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | Cancer-related genes Transcription factors
| | | | | Mixed |
RUNX2 | Runt-related transcription factor 2 | Disease related genes Transcription factors
| | | | | Mixed |
CD2AP | CD2-associated protein | Disease related genes
| | | | | Expressed in all |
MCM3 | Minichromosome maintenance complex component 3 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
GCLC | Glutamate-cysteine ligase, catalytic subunit | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | | Tissue enhanced |
MYO6 | Myosin VI | Disease related genes Plasma proteins
| | | | | Mixed |
HMGN3 | High mobility group nucleosomal binding domain 3 | | | | | | Expressed in all |
PGM3 | Phosphoglucomutase 3 | Enzymes
| | | | | Expressed in all |
SYNCRIP | Synaptotagmin binding, cytoplasmic RNA interacting protein | Plasma proteins
| | | | | Expressed in all |
MANEA | Mannosidase, endo-alpha | Enzymes Predicted membrane proteins
| | | | | Mixed |
UFL1 | UFM1-specific ligase 1 | | | | | | Expressed in all |
FYN | FYN oncogene related to SRC, FGR, YES | Enzymes Plasma proteins
| | | | | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GJA1 | Gap junction protein, alpha 1, 43kDa | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
RNF146 | Ring finger protein 146 | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
EPB41L2 | Erythrocyte membrane protein band 4.1-like 2 | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
MAP7 | Microtubule-associated protein 7 | | | | | | Mixed |
AKAP12 | A kinase (PRKA) anchor protein 12 | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |